Results 21 to 30 of about 67,197 (120)

Robotic enucleation of a biliary adenofibroma. [PDF]

open access: yesBMJ Case Rep, 2021
A 69-year-old man was referred to the hepatobiliary surgeons for mild enlargement of an asymptomatic cystic liver lesion found on routine screening in 2017 that measured 3.7×3.6×4.3 cm.
Blears E, Uemura T, Bunker M.
europepmc   +5 more sources

Imaging presentation of biliary adenofibroma: A case report. [PDF]

open access: yesWorld J Clin Cases, 2022
Biliary adenofibroma (BF) is a rare benign epithelial tumor with the possibility of malignant transformation. Its main pathological feature is a well-defined cystic or honeycomb mass. BF has no specific clinical manifestations or laboratory and imaging findings; thus, it is easily misdiagnosed before surgery.
Li SP, Wang P, Deng KX.
europepmc   +3 more sources

Biliary adenofibroma. Radiological evaluation of the second case in literature

open access: yes, 1997
In this case report, we describe a giant biliary tumor of 20 cm in diameter in the right robe of the liver of a 21-year-old male. The distinctive pathological diagnosis of 'biliary adenofibroma with malignant epithelial transformation' and the ...
Goktay, A.Y.   +5 more
core   +3 more sources

Incidental biliary adenofibroma with dysplastic features. [PDF]

open access: yesBJR Case Rep, 2015
We present a case of an incidentally detected cystic liver mass on CT scan, with histology showing biliary epithelium embedded in fibrous stroma and dysplastic features, consistent with an adenofibroma. This is only the third case described in the literature with malignant histology and the first case with angiographic imaging and subsequent management
Jacobs MA, Lanciault C, Weinstein S.
europepmc   +3 more sources

Biliary adenofibroma with heterogeneous hyperplasia: A case report

open access: yesAsian Journal of Surgery
Yuting Shi   +3 more
doaj   +2 more sources

Imaging Features of Biliary Adenofibroma With Malignant Transformation: A Case Report and Literature Review. [PDF]

open access: yesCureus
Biliary adenofibroma (BAF) is a rare benign tumor, but it has the potential for malignant transformation. The differentiation between benign and malignant forms of BAF before surgery is of great importance for clinical decision-making. We report a case of BAF with invasive carcinoma.
Zhang Y, Chen Q, Shi Y, Wang F, Hu H.
europepmc   +3 more sources

Double Trouble: A Rare Case of Concurrent Biliary Adenofibroma and Hepatobiliary Mucinous Cystic Neoplasm. [PDF]

open access: yesACG Case Rep J, 2018
Biliary adenofibroma and hepatobiliary mucinous cystic neoplasm are exceedingly rare tumors. To our knowledge, no case of co-existent biliary adenofibroma and mucinous cystic neoplasm has been previously reported. We present a patient who was diagnosed with both tumors concurrently.
Esteban M   +4 more
europepmc   +3 more sources

Drug therapy of primary biliary diseases: classical and modern strategies [PDF]

open access: yes, 2013
Definition: Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are both cholestatic liver diseases. A common feature of these disorders is the accumulation of bile acids in the liver and blood, presumably because of decreased ...
Leuschner, Ulrich, Schlichting, Julia
core   +1 more source

Dietary N-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease [PDF]

open access: yes, 1992
Because fatty acid composition of biliary phospholipids influences cholesterol secretion into bile, we investigated whether replacement of n-1 monounsaturated or n-6 polyunsaturated fatty acids with n-3 polyunsaturated fatty acids in biliary ...
Sven Fischer   +13 more
core   +1 more source

Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis. [PDF]

open access: yes, 1985
One hundred and eighty nine patients with primary biliary cirrhosis were entered into a double blind, placebo controlled randomised trial starting in January 1978 to assess the therapeutic value of d-penicillamine 1200 mg daily.
Tygstrup, Niels   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy